Literature DB >> 11531316

Dengue and other emerging flaviviruses.

T Solomon1, M Mallewa.   

Abstract

Flaviviruses are among the most important emerging viruses known to man. Most are arboviruses (arthropod-borne) being transmitted by mosquitoes or ticks. They derived from a common ancestor 10-20000 years ago and are evolving rapidly to fill new ecological niches. Many are spreading to new geographical areas and causing increased numbers of infections. Traditionally, three clinical syndromes are recognized: fever-arthralgia-rash, viral haemorrhagic fever, and neurological disease, though for some flaviviruses the disease pattern is changing. Dengue, the most important flavivirus, is transmitted between humans by Aedes mosquitoes. Recent work is elucidating the pathogenesis of its most severe form, dengue haemorrhagic fever. Yellow fever, which has epidemiological similarities to dengue, was under control in the mid-20th century, but is once again increasing. Japanese encephalitis virus is numerically the most important cause of epidemic encephalitis; its geographical area is expanding despite the availability of vaccines. Other mosquito-borne neurotropic flaviviruses with clinical and epidemiological similarities are found across the globe. These include St Louis encephalitis virus, Murray Valley encephalitis virus, and West Nile virus, which recently reached the Americas for the first time. In cooler northern climates ticks are more important vectors. Tick-borne encephalitis virus occurs across large parts of Eastern Europe and the Commonwealth of Independent states. The tick-borne haemorrhagic flaviviruses, Omsk haemorrhagic fever and Kyasanur Forrest disease are localized in small areas.

Entities:  

Mesh:

Year:  2001        PMID: 11531316     DOI: 10.1053/jinf.2001.0802

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  48 in total

1.  Print media coverage of risk-risk tradeoffs associated with West Nile encephalitis and pesticide spraying.

Authors:  John P Roche
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

2.  Visualization of membrane protein domains by cryo-electron microscopy of dengue virus.

Authors:  Wei Zhang; Paul R Chipman; Jeroen Corver; Peter R Johnson; Ying Zhang; Suchetana Mukhopadhyay; Timothy S Baker; James H Strauss; Michael G Rossmann; Richard J Kuhn
Journal:  Nat Struct Biol       Date:  2003-10-05

3.  Concurrent dengue virus and Japanese encephalitis virus infection of the brain: is it co-infection or co-detection?

Authors:  R K Garg; H S Malhotra; A Gupta; N Kumar; A Jain
Journal:  Infection       Date:  2012-06-14       Impact factor: 3.553

4.  Zika Virus: An Emergence of a New Arbovirus.

Authors:  Sankalp Yadav; Gautam Rawal; Mudit Baxi
Journal:  J Clin Diagn Res       Date:  2016-07-01

5.  Small molecule grp94 inhibitors block dengue and Zika virus replication.

Authors:  Hussin A Rothan; Yongwang Zhong; Mark A Sanborn; Teow Chong Teoh; Jingjing Ruan; Rohana Yusof; Jun Hang; Mark J Henderson; Shengyun Fang
Journal:  Antiviral Res       Date:  2019-08-14       Impact factor: 5.970

6.  Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

Review 7.  Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations.

Authors:  James A Potts; Alan L Rothman
Journal:  Trop Med Int Health       Date:  2008-09-16       Impact factor: 2.622

8.  West nile virus: current perspectives.

Authors:  Om Prakash; George Pankey
Journal:  Ochsner J       Date:  2003

9.  Enhanced West Nile virus surveillance in a dengue-endemic area--Puerto Rico, 2007.

Authors:  Jomil M Torres-Aponte; Richard R Luce; Elizabeth Hunsperger; Jorge L Muñoz-Jordan; Manuela Beltrán; Edgardo Vergne; D Fermín Argüello; Enid J García; Wellington Sun; Kay M Tomashek
Journal:  Am J Trop Med Hyg       Date:  2013-03-11       Impact factor: 2.345

10.  Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens.

Authors:  Wayne D Crill; Holly R Hughes; Mark J Delorey; Gwong-Jen J Chang
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.